Cargando…

Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives

Neoadjuvant chemotherapy (NAC) for locally advanced gastric cancer (LAGC) has been recognized as an effective therapeutic option because it is expected to improve the curative resection rate by reducing the tumor size and preventing recurrence of micrometastases. However, for patients resistant to N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Yasushi, Okamoto, Koichi, Kawaguchi, Tomoyuki, Nakamura, Fumika, Miyamoto, Hiroshi, Takayama, Tetsuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312565/ https://www.ncbi.nlm.nih.gov/pubmed/35884916 http://dx.doi.org/10.3390/biomedicines10071614

Ejemplares similares

Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
por: Sato, Yasushi, et al.
Publicado: (2023)

Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
por: Kida, Yoshifumi, et al.
Publicado: (2023)

Overview of Chemotherapy for Gastric Cancer
por: Sato, Yasushi, et al.
Publicado: (2023)

Clinicopathological characteristics of early gastric cancer associated with autoimmune gastritis
por: Kitamura, Shinji, et al.
Publicado: (2021)

Epidermal growth factor receptor‐targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models
por: Miyamoto, Yoshihiko, et al.
Publicado: (2019)

“Tip-in underwater endoscopic mucosal resection” without submucosal injection for superficial nonampullary duodenal adenomas
por: Okamoto, Koichi, et al.
Publicado: (2023)

Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map
por: Wada, Hironori, et al.
Publicado: (2022)

TIMP1 promotes cell proliferation and invasion capability of right‐sided colon cancers via the FAK/Akt signaling pathway
por: Ma, Beibei, et al.
Publicado: (2022)

Endoscopic Molecular Imaging: Status and Future Perspective
por: Muguruma, Naoki, et al.
Publicado: (2013)

Current status and future perspectives on neoadjuvant therapy in gastric cancer
por: Ao, Sheng, et al.
Publicado: (2021)

A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors
por: Fujimoto, Shota, et al.
Publicado: (2018)

Detection of aberrant crypt foci with image-enhanced endoscopy
por: Kagemoto, Kaizo, et al.
Publicado: (2018)

Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2020)

MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Hirao, Akihiro, et al.
Publicado: (2021)

Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females
por: Sogabe, Masahiro, et al.
Publicado: (2022)

Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab
por: Sagawa, Tamotsu, et al.
Publicado: (2020)

Paraneoplastic Hypocalcemia Developed in Gastric Cancer Accompanied by Osteoblastic Metastasis
por: Okazaki, Jun, et al.
Publicado: (2017)

Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression
por: Takehara, Masanori, et al.
Publicado: (2020)

High antitumor activity of pladienolide B and its derivative in gastric cancer
por: Sato, Momoko, et al.
Publicado: (2014)

Long-Term Survival due to Chemotherapy including Paclitaxel in a Patient with Metastatic Primary Splenic Angiosarcoma
por: Takehara, Masanori, et al.
Publicado: (2021)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer
por: Sagawa, Tamotsu, et al.
Publicado: (2023)

The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
por: Koerner, Anna S., et al.
Publicado: (2023)

An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration
por: Tanaka, Hironori, et al.
Publicado: (2021)

Differences in Several Factors in the Development of Erosive Esophagitis Among Patients at Various Stages of Metabolic Syndrome: A Cross-Sectional Study
por: Sogabe, Masahiro, et al.
Publicado: (2021)

Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve
por: Tomonari, Tetsu, et al.
Publicado: (2022)

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2023)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
por: Zhu, Zhi, et al.
Publicado: (2020)

Twin Rectal Tonsils Mimicking Carcinoid or Mucosa-Associated Lymphoid Tissue Lymphoma
por: Takehara, Masanori, et al.
Publicado: (2017)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report
por: Sagawa, Tamotsu, et al.
Publicado: (2023)

Laparoscopic Surgery for Advanced Gastric Cancer: Current Status and Future Perspectives
por: Uyama, Ichiro, et al.
Publicado: (2013)

Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
por: Beppu, Naohito, et al.
Publicado: (2023)

Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives
por: Tokunaga, Masanori, et al.
Publicado: (2019)

Erratum for Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
por: Beppu, Naohito, et al.
Publicado: (2023)

Correction to: Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives
por: Tokunaga, Masanori, et al.
Publicado: (2020)

MRI Evaluation of Complete Response of Locally Advanced Rectal Cancer After Neoadjuvant Therapy: Current Status and Future Trends
por: Xu, Qiaoyu, et al.
Publicado: (2021)

Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky
por: NIITSU, Yoshiro, et al.
Publicado: (2022)

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2016)

Potential use of lenvatinib for patients with unresectable hepatocellular carcinoma including after treatment with sorafenib: Real-world evidence and in vitro assessment via protein phosphorylation array
por: Tomonari, Tetsu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4tktn1nrod8ns72h8gl34kd73j